In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
EMA recommends withdrawal of pholcodine medicines from EU market

EMA recommends withdrawal of pholcodine medicines from EU market

by In2Pharma | Dec 15, 2022 | News

Europe EMA’s safety committee, PRAC, has concluded its review of medicines containing pholcodine, which are used in adults and children to treat non-productive (dry) cough and, in combination with other active substances, for the treatment of symptoms of...

Recent Posts

  • Reminder – update RD pregabalin/gabapentin
  • Updated deontological code animal health pharma.be
  • Cover letter variation submission
  • IML Updates Code of Ethics and Hospitality Thresholds
  • Guidance FAMHP on premiums and benefits

Follow Us

  • Facebook
  • LinkedIn
An IQVIA Business

IQVIA Logo
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations.

www.iqvia.com

Contact Us

Privacy Policy | Your Privacy Choices | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com |Terloonststraat 22, 1910 Kampenhout, België